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RESEARCH ARTICLE / ÖZGÜN ARAŞTIRMA
The effects of typical and atypical antipsychotics on the electrical activity of the brain 
in a rat model
Rat modelinde tipik ve atipik antipsikotik ilaçların beyin elektriksel aktivitesi üzerine etkileri
Oytun Erbaş1, Mustafa Yılmaz2
ÖZET
Amaç: Antipsikotik ilaçların beyinde güçlü biyoelektrik ak-
tivite etkilerinin olduğu bilinmektedir. Fakat tipik ve atipik 
antipsikotik ilaçlara bağlı olan elektroensefalografi (EEG) 
değişikliklerinin  karşılaştırmalı  çalışmaları  tartışmalıdır. 
Biz bir rat modelinde tipik ve atipik antipsikotik ilaçların 
beyinde elektriksel aktivitesi üzerine olan etkilerini EEG 
ile karşılaştırmayı amaçladık. 
Yöntemler: Bu çalışmada, 35 adet erişkin erkek Spra-
gue Dawley cinsi rat kullanıldı. Herbiri 7 adet rat içeren 
5 adet grup oluşturuldu. Birinci grup kontrol grubu olarak 
kullanıldı ve intraperitoneal yolla 1 ml/kg salin verildi. Beş 
gün boyunca intraperitoneal olarak haloperidol (1 mg/kg) 
(grup 2), klorpromazin (5 mg/kg) (grup 3), olanzapin (1 
mg/kg) (grup 4) ve ziprasidon (1 mg/kg) (grup 5) verildi. 
Beşinci günün sonunda bütün grupların 30 dakika EEG 
kaydı alındı.
Bulgular: Haloperidol, klorpromazin, olanzapin ve zipra-
sidon gruplarında delta ve teta dalga yüzdelerinin salin 
verilen gruba göre anlamlı düzeyde yüksek olduğu gö-
rüldü  (p<0.001).  Olanzapin  ve  ziprosidon  gruplarındaki 
teta dalgaları haloperidol ve klorpromazin grubuyla kar-
şılaştırıldığında anlamlı düzeyde artmış olarak saptandı 
(p<0,05).
Sonuç: Olanzapin ve ziprasidon tipik antipsikotik ilaçlara 
göre EEG de daha az yavaş aktiviteye neden olabilir. Bu 
çalışma antipsikotik ilaçlarin dikkatli kullanılması gerekti-
ğini gösteriyor.
Anahtar kelimeler: Haloperidol,  klorpromazin,  olanza-
pin, ziprasidon, EEG, rat
ABSTRACT
Objective: Antipsychotic drugs are known to have strong 
effect  on  the  bioelectric  activity  in  the  brain.  However, 
some studies addressing the changes on electroenceph-
alography (EEG) caused by typical and atypical antipsy-
chotic drugs are conflicting. We aimed to compare the ef-
fects of typical and atypical antipsychotics on the electri-
cal activity in the brain via EEG recordings in a rat model.
Methods:  Thirty-two  Sprague  Dawley  adult  male  rats 
were used in the study. The rats were divided into five 
groups, randomly (n=7, for each group). The first group 
was used as control group and administered 1 ml/kg sa-
line intraperitoneally (IP). Haloperidol (1 mg/kg) (group 2), 
chlorpromazine (5 mg/kg) (group 3), olanzapine (1 mg/kg) 
(group 4), ziprasidone (1 mg/ kg) (group 5) were injected 
IP for five consecutive days. Then, EEG recordings of 
each group were taken for 30 minutes.
Results: The percentages of delta and theta waves in 
haloperidol, chlorpromazine, olanzapine and ziprasidone 
groups were found to have a highly significant difference 
compared with the saline administration group (p<0.001). 
The  theta  waves  in  the  olanzapine  and  ziprasidone 
groups were increased compared with haloperidol and 
chlorpromazine groups (p<0.05).
Conclusion: The typical and atypical antipsychotic drugs 
may  be  risk  factor  for  EEG  abnormalities.  This  study 
shows that antipsychotic drugs should be used with cau-
tion. J Clin Exp Invest 2013; 4 (3): 279-284
Key words: Haloperidol,  chlorpromazine,  olanzapine, 
ziprasidone, EEG, rat
INTRODUCTION
Antipsychotic  drugs  are  more  often  used  in  the 
treatment  of  psychosis,  impulse  control  disorders 
and other psychiatric conditions [1,2].
First-generation antipsychotics (FGAs) such as 
haloperidol, chlorpromazine are lipophilic and hav-
ing high protein and large volumes of distribution. In 
addition, they have role in severe problems such as 
reducing thinking, mood and behavior [3]. The typi-
cal agents often lead to extrapyramidal side effects 
including  rigidity,  bradykinesia,  tremor,  akathisia, 
and tardive dyskinesia [4]. Therefore, typical agents 
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antipsychotics (SGAs) such as olanzapine, ziprasi-
done. Besides, the general belief is that the SGAs 
are effective in terms of efficacy and safety in treat-
ment of psychiatric disease [5]. There has not been 
many studies available comparing the adverse ef-
fects of antipsychotics in the brain. Some studies 
have reported that risk of epileptic seizure depend-
ing on the effect of antipsychotics in patients [6,7].
Electroencephalography (EEG) was introduced 
to study brain dysfunction. It is the gold standard 
for the diagnosis and treatment of epilepsy [9]. EEG 
not only provides information about epileptic activity 
but also generates rhythmic activity in several fre-
quency ranges [10,11,15,16]. In previous studies, it 
was determined that EEG abnormalities have been 
found  in  schizophrenia  and  manic  patients  [17]. 
The antipsychotics are known to have a strong in-
fluence on the bioelectric activity in the brain [11]. 
EEG abnormalities during antipsychotic treatment 
are common and are also particularly dose-depen-
dent [12,13]. Spectral analysis is a representation 
of the signal’s amplitude as a function of frequency. 
Power spectral analysis (PSA) is one of the stan-
dard methods used for the quantification of EEG. 
The PSA can be used to accurately measure the 
frequency  content  and  distribution  of  power  over 
the frequencies [14]. It was found in approximately 
10% of the cases on usage antipsychotic drugs that 
epileptic activity such as spikes, poly-spikes, and 
spike-wave complexes increased in slow-wave ac-
tivity and high-voltage theta-delta groups.
Antipsychotics  treatment  is  a  risk  factor  for 
epilepsy. Epilepsy is a high risk factor for subse-
quent cognitive impairment, especially for early on-
set of seizures. Due to the treatment affects both 
the direct and indirect thresholds for epilepsy and 
cognitive functions, it is important that limited us-
age the antipsychotic drugs. Drugs to be used in 
schizophrenia patients with cognitive impairments 
should  have  the  least  negative  effects  on  cogni-
tive performance [4]. Despite the high utilization of 
EEG in psychotic patients with seizures, few studies 
examined the relationship between brain rhythms, 
as measured by EEG, and compared the effects of 
typical and atypical antipsychotics on the brain. In 
the study, we aimed to evaluate PSA using EEG in 
the treatment of typical and atypical antipsychotics 
on experimental rat models.
METHODS
The study was performed at the Electrophysiology 
Research Laboratory of the Department of Physiol-
ogy, Faculty of Medicine, Ege University after ob-
taining Animal Ethics Committee approval. Thirty-
five male Sprague Dawley rats at 8 weeks, weigh-
ing 450-500 g, were used for the study. The animals 
were  fed  ad  libitum  and  housed  in  pairs  in  steel 
cages having a temperature-controlled environment 
(22±2°C)  with  12-h  light/dark  cycles.  The  experi-
mental procedures were approved by the Commit-
tee for Animal Research. All animal studies strictly 
conformed to the animal experiment guidelines of 
the Committee for Humane Care. Rats were anes-
thetized by combination of ketamine hydrochloride 
at a dose of 40 mg/kg (Alfamine®, Ege Vet, Alfasan 
International B.V. Holland) and 4 mg/kg of xylazine 
hydrochloric (Alfazyne®, Ege Vet, Alfasan Interna-
tional B.V. Holland) which was administered intra-
peritoneally (IP). One week before testing, the rats 
implanted, under anesthesia, with the outer parts of 
the isolated bipolar EEG electrodes (100 µm diam-
eter) were placed in the basolateral amygdala with 
coordinates AP=2.8 mm, L=4.8 mm and V=8.5 mm 
(Paxinos). The electrodes were fixed in cranium us-
ing cold acrylic (numerous alloys are used in the 
making of dental restorations). The rats were divided 
randomly into five groups. The first group was used 
as control group and administered1 mL/kg saline. 
Haloperidol  (1  mg/kg)  (group  2),  chlorpromazine 
(5 mg/kg) (group 3), olanzapine (1 mg/kg) (group 
4), ziprasidone (1 mg/kg) (group 5) were injected 
IP for five consecutive days. Then, EEG recording 
of each group was taken 30 minutes. EEG record-
ings were taken in the range of 1-60 Hz band with 
10.000  fold  amplification.  Recordings  were  taken 
by a Biopac MP30 amplifier and evaluated by PSA 
method. Delta waves=1-4 Hz, theta waves=4-8 Hz, 
alpha waves=8-12 Hz, beta waves=12-20 Hz were 
accepted and a percentage of the waves are evalu-
ated in the EEG.
Statistical Analysis
Data  analyses  were  performed  using  Statistical 
Package for the Social Sciences version 15.0 for 
windows (SPSS Inc., Chicago, IL, USA) statistical 
package program. The groups of parametric vari-
ables were compared by Student’s t-test and analy-
sis of variance (ANOVA). The groups of nonpara-
metric variables were compared by Mann Whitney 
U test. Shapiro-Wilk test was used to parametric-
nonparametric  differentiation.  Results  were  given 
as mean±standard error of mean (SEM). A value 
of p<0.05 was accepted as statistically significant. 
p<0.001 was accepted as statistically highly signifi-
cant.Erbaş and Yılmaz. Antipsychotics and brain’s electrical activity in rats 281
J Clin Exp Invest   www.jceionline.org   Vol 4, No 3, September 2013
RESULTS
The percentages of delta waves in groups including 
haloperidol, chlorpromazine, olanzapine, and zipra-
sidone were highly significant difference compari-
son to control group (p<0.001) (Figure 1). Increased 
delta waves in fourth and fifth groups were lower 
than second and third groups (p<0.05).
The  percentages  of  theta  waves  in  the  sec-
ond, third, fourth and fifth groups were significantly 
decreased compared with control group (p<0.001) 
(Figure 2). The decreased theta waves in fourth and 
fifth  groups  were  lower  than  the  chlorpromazine 
group (p<0.05).
The percentages of alpha waves in haloperi-
dol,  chlorpromazine,  olanzapine  and  ziprasidone 
groups  were  significantly  different  compared  with 
the control group (p<0.001) (Figure 3). The alpha 
waves in olanzapine and ziprasidone groups were 
decreased  compared  with  haloperidol  and  chlor-
promazine groups (p<0.05).
The beta waves were significantly increased in 
haloperidol, chlorpromazine and olanzapine groups 
compared with control group (p<0.05) (Figure 4). 
There were no significant differences in the ziprasi-
done group compared with the control group.
Groups Delta waves Theta waves Alpha waves Beta waves
Controls 5.77±1.12 85.55±2.77 2±0.52 2.11±1.11
Haloperidol group 21.22 ± 2.78** 54.11 ± 5.50** 10.11 ± 1.61* 6.66 ± 0.89*
Chlorpromazine group 22.88±2.13** 52.33±5.08** 9.66±1.46** 7.11±1.34*
Olanzapine group 15.33±2.67** 69.33±4.95** 6.55±1.11* 7.77±2.50*
Ziprasidone group 16.44±1.90** 67.33±3.22** 5.94±0.99* 3.5±0.82
*p<0.05 compared with control group, **p<0.001 compared with control group
Table 1. The per-
centages of delta, 
theta,  alpha  and 
beta  waves  in 
groups.
Figure 1. The analysis of power 
spectral  ratio  (percentages)  of 
delta  wave  in  basolateral  amyg-
dala
Figure 2. The analysis of power 
spectral  ratio  (percentages)  of 
theta  wave  in  basolateral  amyg-
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Figure 3. The analysis of power 
spectral ratio (percentages) of al-
pha wave in basolateral amygdala
Figure 4. The analysis of power 
spectral  ratio  (percentages)  of 
beta  wave  in  basolateral  amyg-
dala
DISCUSSION
EEG abnormalities may be more common with typi-
cal  antipsychotics  than  with  atypical  antipsychot-
ics. In the current study, both typical and atypical 
antipsychotics  drugs  have  been  demonstrated  to 
change the EEG rhythm; and contrary to popular 
belief,  atypical  antipsychotics  drugs  change  the 
EEG rhythm less than typical antipsychotics drugs 
[21,22].  We  investigated  the  changes  caused  by 
four different antipsychotic drugs on EEG. We used 
drugs  such  as  chlorpromazine  and  ziprasidone, 
which have unknown effects on EEG, exactly. 
An animal experimental model was used in the 
study because of the criticism received by previous 
studies conducted on human subjects for not com-
paring pre- and post-treatment EEG, not consider-
ing the stage of the disease, and not investigating 
the  drug  levels  in  the  blood. A  remarkable  EEG 
slowing was observed when the drugs reached a 
stable  blood  plasma  concentration  [14,22].  Slow 
waves were found to occur less with olanzapine, un-
like in previous studies, and ziprasidone. Olanzap-
ine might have caused fewer slow waves on EEG 
compared to typical neuroleptic drugs in our study 
due to the use of healthy animals instead of patients 
[23]. In other words, there are methodological differ-
ences between this study and previous studies in 
the literature. 
High drug dosages, co-morbidity, and the use 
of multiple drugs in combination were all implicated 
in causing epileptic seizures related to antipsychot-
ics.  For  example,  in  one  case,  epileptic  seizures 
developed  during  transition  from  haloperidol  to 
olanzapine. The changes in EEGs caused by an-
tipsychotics are correlated with the concentrations 
of the drugs in the blood and to their anticholinergic 
features [24]. The authors reported that EEG abnor-
mality risk may vary widely among antipsychotics. 
However, it is reported that antipsychotics not only 
cause changes on EEGs, but can also cause epilep-
tic seizures and affect cognitive functions causing 
sleep disturbance [20,25]. Gunther et al. reported 
that clozapine caused both EEG abnormalities and 
epileptic seizures more often compared to neuro-
leptics [13]. Erbaş and Yılmaz. Antipsychotics and brain’s electrical activity in rats 283
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It was recommended that the dose of antipsy-
chotics be adjusted based on the extent of EEG 
slowing and the drug levels in the blood. However, 
EEG slowing occurs with most antipsychotics and 
after  electroconvulsive  therapy  patients  with  psy-
chosis,  without  causing  seizures,  which  suggests 
that the therapeutics provide benefits to the patients 
by slowing down the electrical activity. Therefore, 
incomplete EEG slowing does not seem desirable 
[26,27]. Nevertheless, any EEG abnormalities were 
observed for any of the 12 patients treated with que-
tiapine in a study by Wetzel et al., which demon-
strates that antipsychotics do not provide benefits 
solely when EEG slowing occurs [22]. Antipsychot-
ics are known to have strong effects on bioelectric 
activity in the brain and to cause changes on EEG. 
However, comparative studies of changes on EEG 
caused by typical and atypical antipsychotics are 
still  insufficient.  It  was  reported  that  treatment  of 
clozapine caused slowed down the EEG in half of 
the  patients,  and  epileptiform  disorders  occurred 
in more than 10% of the patients [18,19]. Although 
quetiapine chemically resembles clozapine, it is less 
effective on EEG [18]. Olanzapine, another atypical 
antipsychotic, is also reported to cause EEG slow-
down to a lesser extent compared to clozapine [19]. 
Previous studies showed that EEG abnormali-
ties and seizures were more common with atypical 
antipsychotics than with typical antipsychotics [20]. 
Despite the importance of the current findings, a 
limitation must be mentioned. The effects of anti-
psychotics on the brain cannot be evaluated based 
solely on the slowing of electrical activity observed 
using EEG, and cognitive tests should also be used 
in combination with EEG. Non-comparison of the 
groups with cognitive tests may be considered as 
a weakness of this study. Here, conducting tests 
aimed  at  understanding  whether  antipsychotics 
cause cognitive impairment in rats would have been 
better. However, while the conduct of existing clini-
cal studies on patients with psychosis and despite 
the fact that the changes in EEG may be due to 
both the effects of the psychosis and the antipsy-
chotics are the shortcomings of this study, our study 
aimed to experimentally observe potential changes 
on healthy individuals and rats following administra-
tion of antipsychotics to normal rats.
In  conclusion,  these  data  obtained  from  this 
study  suggested  that  most  slow  waves  on  EEG 
were in the haloperidol and chlorpromazine groups. 
The present data justifies carefully-controlled treat-
ment with antipsychotic drugs. The typical and atyp-
ical antipsychotic drugs may be risk factor for EEG 
abnormalities. This study shows that antipsychotic 
drugs should be used with caution.
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